StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3070% below fair value
$0.63−0.07 (-10.29%)

Close on Nov 20, 2026Market cap $4.78MP/E –Yield –

Cerenome net income

Net income is the profit left for shareholders after every expense, interest and tax.

Cerenome's net income for the twelve months ending Jun 30, 2026 was -$26.09M. For fiscal 2025 it was -$22.39M. The highest annual figure on record is -$8.24M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.39M–
FY2024Dec 31, 2024-$12.98M–
FY2023Dec 31, 2023-$13.32M–
FY2022Dec 31, 2022-$20.28M–
FY2021Dec 31, 2021-$13.40M–
FY2020Dec 31, 2020-$8.24M–
FY2019Dec 31, 2019-$10.89M–
FY2018Dec 31, 2018-$12.63M–
FY2017Dec 31, 2017-$22.69M–
FY2016Dec 31, 2016-$22.05M–
FY2015Dec 31, 2015-$18.74M–
FY2014Dec 31, 2014-$37.37M–
FY2013Dec 31, 2013-$26.18M–
FY2012Dec 31, 2012-$32.28M–
FY2011Dec 31, 2011-$32.45M–
FY2010Dec 31, 2010-$27.49M–
FY2009Dec 31, 2009-$23.22M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.01M-274.8%
Q1 FY2026Mar 31, 2026-$6.95M–
Q4 FY2025Dec 31, 2025-$5.71M–
Q3 FY2025Sep 30, 2025-$4.42M–
Q2 FY2025Jun 30, 2025$5.15M–
Q1 FY2025Mar 31, 2025-$17.40M–
Q4 FY2024Dec 31, 2024-$3.90M–
Q3 FY2024Sep 30, 2024-$2.87M–
Q2 FY2024Jun 30, 2024-$2.94M–
Q1 FY2024Mar 31, 2024-$3.26M–
Q4 FY2023Dec 31, 2023-$3.81M–
Q3 FY2023Sep 30, 2023-$3.22M–
Q2 FY2023Jun 30, 2023-$1.48M–
Q1 FY2023Mar 31, 2023-$4.81M–
Q4 FY2022Dec 31, 2022-$5.66M–
Q3 FY2022Sep 30, 2022-$5.22M–
Q2 FY2022Jun 30, 2022-$5.28M–
Q1 FY2022Mar 31, 2022-$4.12M–
Q4 FY2021Dec 31, 2021-$4.16M–
Q3 FY2021Sep 30, 2021-$3.72M–
Q2 FY2021Jun 30, 2021-$2.80M–
Q1 FY2021Mar 31, 2021-$2.72M–
Q4 FY2020Dec 31, 2020-$3.59M-505.8%
Q3 FY2020Sep 30, 2020-$1.73M-428.5%
Q2 FY2020Jun 30, 2020-$1.84M–
Q1 FY2020Mar 31, 2020-$1.09M–
Q4 FY2019Dec 31, 2019$884.00K–
Q3 FY2019Sep 30, 2019$526.00K–
Q2 FY2019Jun 30, 2019-$9.15M–
Q1 FY2019Mar 31, 2019-$3.15M–
Q4 FY2018Dec 31, 2018-$2.24M–
Q1 FY2018Mar 31, 2018-$4.41M–
Q4 FY2017Dec 31, 2017-$4.29M–
Q3 FY2017Sep 30, 2017-$4.81M–
Q2 FY2017Jun 30, 2017-$6.05M–
Q1 FY2017Mar 31, 2017-$7.54M–
Q4 FY2016Dec 31, 2016-$4.92M–
Q3 FY2016Sep 30, 2016-$5.38M–
Q2 FY2016Jun 30, 2016-$6.41M–

More Cerenome figures

See a number that looks wrong?